Indications
Therapeutic Asset Ratings
5,099 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Nivestim
T-Cell Acute Lymphoblastic Leukemia
Children's Oncology Group
P3
B
(62)
Nivolumab
Nonpapillary Renal Cell Carcinoma
Fred Hutchinson Cancer Center
P3
B
(62)
Nivolumab
Bladder Transitional Cell Carcinoma
Nagoya University
P3
B
(62)
Nivolumab
Metastatic Malignant Neoplasm
Fred Hutchinson Cancer Center
P3
B
(62)
Nivolumab
Primary Mediastinal Large B-Cell Lymphoma
St. Petersburg State Pavlov Medical University
P3
B
(62)
Nivolumab
Urothelial Carcinoma
Fred Hutchinson Cancer Center
P3
B
(62)
Nogitecan
Neoplasm
Actuate Therapeutics Inc.
P3
B
(62)
Obinutuzumab
Diffuse Large B-Cell Lymphoma
National Cancer Institute (NCI)
P3
B
(62)
Obinutuzumab
Marginal Zone Lymphoma
Ruijin Hospital
P3
B
(62)
Orca-T
Mixed Phenotype Acute Leukemia
Orca Biosystems, Inc.
P3
B
(62)
Orelabrutinib
B-Cell Non-Hodgkin Lymphoma
Peking University People's Hospital
P3
B
(62)
Oxaliplatin
Non-Small Cell Lung Carcinoma
Qilu Pharmaceutical Co., Ltd.
P3
B
(62)
Oxaliplatin
Hepatoblastoma
Children's Oncology Group
P3
B
(62)
Oxaliplatin
Pediatric Hepatocellular Carcinoma
Children's Oncology Group
P3
B
(62)
Oxaliplatin
Cholangiocarcinoma
Jonsson Comprehensive Cancer Center
P3
B
(62)
Oxaliplatin
Colorectal Adenocarcinoma
Pfizer
P3
B
(62)
Oxaliplatin
Esophageal Adenocarcinoma
I-Mab Biopharma US Limited
P3
B
(62)
Oxaliplatin
Intestinal Neoplasm
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P3
B
(62)
Oxaliplatin
Neuroendocrine Neoplasm
ITM Solucin GmbH
P3
B
(62)
Oxaliplatin
Ovarian Mucinous Cystadenocarcinoma
National Cancer Institute (NCI)
P3
B
(62)
Oxaliplatin
Relapsed/Refractory Diffuse Large B-Cell Lymphoma
City of Hope Medical Center
P3
B
(62)
Oxodotreotide
Neuroendocrine Neoplasm
Fundación de investigación HM
P3
B
(62)
Oxygen
Traumatic Brain Injury
University of South Florida
P3
B
(62)
Palbociclib
Metastatic Neoplasm
Eli Lilly and Company
P3
B
(62)
Panitumumab
Metastatic Neoplasm
Amgen
P3
B
(62)
Showing 1876 to 1900 of 5,099 assets
Previous
Page 76 of 204
Next